ARCHIVES

FDA News: FDA Grants Accelerated Approval to Mekinist-Tafinlar Combination

This article is from The Cancer Letter archive.

Vol. 40 No. 02 | January 10, 2014

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

July 30, 2004

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

University of Pittsburgh Cancer Institute Wins Core Grant Renewal

October 1, 2010

ACCC Annual Meeting Expands to 4 Days, One On Cancer Control

January 15, 1982

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013

Risk Assessment Program Turns 30: Fox Chase Program Helps People Understand Genetic Risks for Cancer

October 25, 2021